CIK 0001762303
- Non-accelerated filer
- Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202578762
- Phone
- +1 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CFO bought 975 shares at an average $12.46 ($12,152)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 9,200 shares (grant or award)
- 4 Grant or award Director acquired 9,200 shares (grant or award)
- 4 Grant or award Director acquired 9,200 shares (grant or award)
- 4 Grant or award Director acquired 9,200 shares (grant or award)
- 4 Grant or award Director acquired 9,200 shares (grant or award)
- 4 Grant or award Director acquired 9,200 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award General Counsel acquired 2,225 shares (grant or award)
- 4 Open-market buy CFO bought 1,000 shares at an average $8.90 ($8,900)
- 4 Open-market buy CFO bought 1,250 shares at an average $17.39 ($21,738)
- 4 Grant or award General Counsel acquired 1,469 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 1,445 shares at $13.29 ($19,204)
- 4/A Open-market sale Director sold 2,500 shares at $12.49 ($31,225)
- 4 Open-market sale Director sold 2,518 shares at $12.27 ($30,896)
- 4 Open-market buy CFO bought 950 shares at $12.45 ($11,828)
Page 3 of 7 · 140 filings